Improving Cancer Treatment with Cancer Treatment Centers of America

Cancer Treatment Centers of America has partnered with Allscripts and NantHealth to create Clinical Pathways, a new treatment platform for more effective cancer treatment regimens. Clinical Pathways allows physicians and patients to choose the best possible treatment options by providing a menu of pre-approved, evidence-based treatment plans. Designed with input from hundreds of oncologists from across the country, Clinical Pathways integrates Nanthealth’s eviti ® with Allscripts Sunrise electronic health records to allow immediate insurance pre-authorization for approved, evidence-based treatments. By directly integrating into patients’ electronic health records, this new service will reduce the number of insurance denials and appeals. Physicians may choose from over 2700 evidence-based treatment options, curated from peer-reviewed literature, oncology associations, and governmental agencies.

“We created an ecosystem of treatment options, customized to the CTCA standard of care, for patients to review and choose from that’s safe and efficient,” said George Daneker, Jr., MD, Chief Medical Officer at CTCA ® at Southeastern Regional Medical Center.

About Cancer Treatment Centers of America

As stated on Wikipedia, founded by Richard J. Stephensen in 1988, Cancer Treatment Centers of America is a, national network of five hospitals serving adult cancer patients across the country. With hospitals in Atlanta, Chicago, Philadelphia, Phoenix, and Tulsa, Cancer Treatment Centers of America provides conventional, evidence-based cancer treatments alongside integrated therapies designed to improve the quality of life of patients.

Cancer Treatment Centers of America recognizes the unique and individual nature of cancer and therefore utilizes the most cutting-edge treatments and regimens to provide the best possible outcomes for patients. Contact Cancer Treatment Centers of America for more information on treatment options and to learn more.

For more information follow CTCA on Twitter.